Condition

Cancer, Advanced

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 4 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials4

Recruiting1

Common interventions7

Lead sponsors shown4

Clinical trials

4 shown

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryNCT03452774 · 2018-01-01

RECRUITING

The Registry of Oncology Outcomes Associated With Testing and TreatmentNCT04028479 · 2021-05-05

COMPLETED

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)NCT03896958 · 2019-03-21

UNKNOWN

Chemoradiation vs Immunotherapy and Radiation for Head and Neck CancerNCT03383094 · 2018-03-15

ACTIVE_NOT_RECRUITING

Common interventions

Biomarker Testing (L)DIAGNOSTIC_TEST1 CisplatinDRUG1 Clinical Trial MatchingOTHER1 Patient Reported Outcomes (P)OTHER1 PembrolizumabDRUG1 Radiation therapyRADIATION1 Systemic Treatment (T)DRUG1

Leading sponsors

Loren Mell, MD 1 Massive Bio, Inc. 1 SpeciCare 1 Taproot Health 1

Trial status mix

ACTIVE_NOT_RECRUITING1

COMPLETED1

RECRUITING1

UNKNOWN1

Phase mix

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.